Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is mainly characterized by movement dysfunction. Neurovascular unit (NVU) disruption has been proposed to be involved in the disease, but its role in PD neurodegenerative mechanisms is still unclear. The aim of this study was to investigate cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) within the regions belonging to the motor network, in patients with mild to moderate stages of PD. Methods: Twenty-eight PD patients (66.6 ± 8.6 years, 22 males, median [interquartile range, IQR] Hoehn & Yahr = 1.5 [1–1.9]) and 32 age- and sex-matched healthy controls (HCs) were scanned with arterial spin labeling (ASL) magnetic resonance imaging (MRI) for CBF assessment. ASL MRI was also acquired in hypercapnic conditions to induce vasodilation and subsequently allow for CVR measurement in a subgroup of 13 PD patients and 13 HCs. Median CBF and CVR were extracted from cortical and subcortical regions belonging to the motor network and compared between PD patients and HCs. In addition, the correlation between these parameters and the severity of PD motor symptoms [quantified with Unified Parkinson’s Disease Rating Scale part III (UPDRS III)] was assessed. The false discovery rate (FDR) method was used to correct for multiple comparisons. Results: No significant differences in terms of CBF and CVR were found between PD patients and HCs. Positive significant correlations were observed between CBF and UPDRS III within the precentral gyrus, postcentral gyrus, supplementary motor area, striatum, pallidum, thalamus, red nucleus, and substantia nigra (pFDR < 0.05). Conversely, significant negative correlation between CVR and UPDRS III was found in the corpus striatum (pFDR < 0.05). Conclusion: CBF and CVR assessment provides information about NVU integrity in an indirect and noninvasive way. Our findings support the hypothesis of NVU involvement at the mild to moderate stages of PD, suggesting that CBF and CVR within the motor network might be used as either diagnostic or prognostic markers for PD.

[1]  Christopher G. Goetz Chairperson,et al.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004 .

[2]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[3]  W. Poewe,et al.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[4]  I. Rektorová,et al.  Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson’s disease , 2017, Journal of Neural Transmission.

[5]  P. Pollak,et al.  Levodopa does not change cerebral vasoreactivity in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[6]  J. Bart,et al.  Blood–brain barrier dysfunction in parkinsonian midbrain in vivo , 2005, Annals of neurology.

[7]  E. Miyoshi,et al.  Abnormal Cerebrovascular Reactivity in Patients with Parkinson's Disease , 2015, Parkinson's disease.

[8]  S. McEwen,et al.  Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease , 2013, The Lancet Neurology.

[9]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[10]  J. Woulfe,et al.  Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  T. Spires-Jones,et al.  A brain boost to fight Alzheimer's disease , 2018, Science.

[12]  Alfonso Barrós-Loscertales,et al.  Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements , 2007, Brain Research.

[13]  M. Hallett,et al.  Parkinson’s disease as a system-level disorder , 2016, npj Parkinson's Disease.

[14]  P. Calabresi,et al.  Complexity of Motor Sequences and Cortical Reorganization in Parkinson's Disease: A Functional MRI Study , 2013, PloS one.

[15]  S. Rauch,et al.  Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. , 2005, The American journal of psychiatry.

[16]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[17]  Manus J. Donahue,et al.  Neuroimaging of vascular reserve in patients with cerebrovascular diseases , 2017, NeuroImage.

[18]  L. McGuinness,et al.  Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease , 2015, Neurobiology of Disease.

[19]  M. Oda,et al.  Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features. , 2005, Parkinsonism & related disorders.

[20]  A. Członkowska,et al.  Cerebral vasomotor reactivity in neurodegenerative diseases. , 2016, Neurologia i neurochirurgia polska.

[21]  T. Grabowski,et al.  Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[22]  W. Poewe,et al.  The reorganization of functional architecture in the early-stages of Parkinson's disease. , 2018, Parkinsonism & related disorders.

[23]  Richard Watts,et al.  Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. , 2011, Brain : a journal of neurology.

[24]  Marcella Laiacona,et al.  Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms and equivalent scores , 2015, Neurological Sciences.

[25]  Mark Jenkinson,et al.  The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis , 2012, Human brain mapping.

[26]  J. Labandeira-Garcia,et al.  Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β , 2014, Experimental Neurology.

[27]  Hong Yu,et al.  Role of hyperactive cerebellum and motor cortex in Parkinson's disease , 2007, NeuroImage.

[28]  M. Giannelli,et al.  Hypoactivation of the primary sensorimotor cortex in de novo Parkinson’s disease , 2012, Neuroradiology.

[29]  Iracema Leroi,et al.  Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease , 2014, NeuroImage: Clinical.

[30]  A. Rodriguez-Perez,et al.  Dopamine‐Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[31]  V. Blasi,et al.  Functional brain changes in early Parkinson's disease during motor response and motor inhibition , 2011, Neurobiology of Aging.

[32]  E. Hirsch,et al.  Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian , 2005, Journal of Neural Transmission.

[33]  M. Mallar Chakravarty,et al.  Multi-contrast unbiased MRI atlas of a Parkinson’s disease population , 2015, International Journal of Computer Assisted Radiology and Surgery.

[34]  S. Gatzonis,et al.  Parkinson's disease pathogenesis, evolution and alternative pathways: A review. , 2018, Revue neurologique.

[35]  Whitney B. Pope,et al.  Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke — Comparison with dynamic susceptibility contrast enhanced perfusion imaging☆ , 2013, NeuroImage: Clinical.

[36]  Y. Sohn,et al.  Cerebral microbleeds in patients with Parkinson’s disease , 2014, Journal of Neurology.

[37]  Y. Carmi,et al.  The role IL-1 in tumor-mediated angiogenesis , 2014, Front. Physiol..

[38]  R. Barker,et al.  Parkinson's disease and healthy aging: Independent and interacting effects on action selection , 2010, Human brain mapping.

[39]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[40]  Y. Itoyama,et al.  Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease , 2001, Journal of the Neurological Sciences.

[41]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[42]  Peiying Liu,et al.  Impaired cerebrovascular reactivity in multiple sclerosis. , 2014, JAMA neurology.

[43]  Asmaa M S Gomaa,et al.  Vulnerability of glia and vessels of rat substantia nigra in rotenone Parkinson model , 2018, Ultrastructural pathology.

[44]  Mark W. Woolrich,et al.  Variational Bayesian Inference for a Nonlinear Forward Model , 2020, IEEE Transactions on Signal Processing.

[45]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.